Strategies for Cancer Immunotherapy Development: Preclinical Studies
$4,095,431ZIAFY2024CANIH
Division Of Basic Sciences - Nci
Investigators
Linked publications & trials
Paper 38427670Paper 37371081Paper 37166485Paper 36410696Paper 36054490Paper 35764364Paper 35473390Paper 35260537Paper 35230974Paper 34145272Paper 34079772Paper 33996267Paper 33741731Paper 33669155Paper 33651712Paper 33602696Paper 33355290Paper 33033852Paper 32651586Paper 32439799Paper 32373533Paper 32345623Paper 32303618Paper 32188703Paper 32159390Paper 31645354Paper 30898149Paper 30846174Paper 30713787Paper 29925431Paper 29891204Paper 29721396Paper 29392336Paper 29207606Paper 29103968Paper 29088859Paper 29088720Paper 28753113Paper 28477372Paper 28423552Paper 27861156Paper 27350882Paper 27192116Paper 27172898Paper 26921031Paper 26910920Paper 26374823Paper 26317648Paper 26014098Paper 25605015Paper 24886178Paper 24815864Paper 24681847Paper 24520078Paper 24516200Paper 24233342Paper 24125763Paper 23904158Paper 23677477Paper 23483661Paper 23319273Paper 22932804Paper 22611028Paper 22595046Paper 22450814Paper 22395641Paper 22251077Paper 21952287Paper 21427233Paper 21318157Paper 20976449Paper 20965561Paper 20664357Paper 20364378Paper 20091862Paper 19756595Paper 19638573Paper 19450631Paper 19319531Paper 19276249Paper 19110021Paper 18794077Paper 18424706Paper 18354238Paper 18281535Paper 18256832Paper 18155327
View original record on NIH RePORTER →